IL1B and neoplasm: Genetic Il1b ablation in the TME significantly prolonged the survival of tumor-bearing mice, recapitulating the results of the RCAS/Ntv-a system and suggesting that this beneficial effect of Il1b loss is a TME-driven effect (Figure 3C).